BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.6.1//EN
X-ORIGINAL-URL:https://www.ai-mind.eu/
X-WR-CALNAME:AI-Mind
X-WR-CALDESC:Artificial Intelligence for Dementia Prevention
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-5f7020a8356d965f6c2fb42887d3df0f@ai-mind.eu
DTSTART:20220625T060000Z
DTEND:20220629T160000Z
DTSTAMP:20220614T100000Z
CREATED:20220614
LAST-MODIFIED:20220712
PRIORITY:5
SEQUENCE:1
TRANSP:OPAQUE
SUMMARY:Health Technology Assessment international (HTAi) 2022 Annual Meeting
DESCRIPTION:Health Technology Assessment international (HTAi) ( https://www.htai2022.org/about-htai ) is the global scientific and professional society for everyone who produces, uses, or encounters Health Technology Assessment to support optimal policy and decision making.  Its mission is to support the growth of the HTA community by providing a neutral, global forum for the exchange of information, methods and expertise. With members from over 60 countries and across six continents, HTAi is a thriving global network.\nHeld each year in June, the HTAi Annual Meeting is a key international gathering for sharing latest research, advancing discussions in policy and methods, and building global networks. The Annual Meeting supports the mission of HTAi to promote the development, understanding and use of HTA around the world as a means of fostering innovation and effective use of resources in health care.\n\n\n\n\nFor the health technology assessment (HTA) community to transition and for individual HTA bodies to find their place in a more proactive, global ecosystem that considers whole system value, key questions must be urgently addressed with stakeholders across the lifecycle. Main questions are:\n\n\n\n\n\nWhat are the implications for the position and role of HTA in healthcare decision-making at a global level and potential for HTA bodies to participate across the whole lifecycle of health technologies?\nHow does a lifecycle approach to HTA contribute to legitimacy, relevance, and public confidence in healthcare decision-making?\nWhat are the implications of taking a lifecycle approach for setting HTA priorities and ensuring sustainability of the HTA process?\nHow can unmet medical need influence HTA priority setting, and which elements of unmet medical need should be considered?\nWhat does effective and efficient integration of stakeholder perspectives look like in a lifecycle approach?\nWhat are best practices in terms of interaction between different healthcare authorities and how do they perceive different types of evidence over the lifecycle of health technologies?\nHow do other stakeholders such as innovators and patients feel this interaction between healthcare authorities and what improvements do they seek?\n\n\n\n\n\n\nBuilding on initiatives from a variety of HTA bodies and previous HTAi Annual Meeting and Policy Forum, the HTAi 2022 Annual Meeting will offer a global platform to deepen awareness of the consequences of a lifecycle approach to HTA from pre-market, market approval, post-market and disinvestment; improve knowledge of suitable methods and processes; strengthen connections across stakeholders; and prioritize activities.\nHTAi invites those with an interest in finding answers to these challenges to come together to make a lifecycle approach happen when HTAi 2022 Annual Meeting is held in Utrecht and virtually, on June 25- 29, 2022.\nAccess to the website: https://bit.ly/3ytnIei ( https://bit.ly/3ytnIei )\n\n\n\n\n\n
URL:https://www.ai-mind.eu/events/health-technology-assessment-international-htai-2022-annual-meeting/
CATEGORIES:Conference,External event
LOCATION:Ultrecht, Netherlands
ATTACH;FMTTYPE=image/jpeg:https://www.ai-mind.eu/wp-content/uploads/sites/39/2022/06/callum-parker-ClzrGdUNfXc-unsplash-scaled-e1676964023721.jpg
END:VEVENT
END:VCALENDAR